Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

CBD Oil Market Size to Reach USD 18.34 Billion by 2033

10 Mar 2025
Healthcare and Pharmaceuticals

CBD Oil Market, valued at USD 5.24 Billion in 2024, is anticipated to reach USD 18.34 Billion by 2033, indicating a robust CAGR of 15.1%

CBD oil is a natural extract obtained from the Cannabis sativa plant, primarily hemp, with cannabidiol (CBD) as the active ingredient. It is widely utilized in a variety of industries to treat pain, anxiety, inflammation, and overall wellness. CBD oil, which is available in a variety of forms such as tinctures, capsules, topicals, and edibles, is becoming increasingly popular in the medical and consumer industries.

CBD Oil Market Statistics

CBD oil's future lies in its expanded applications in medicines, nutraceuticals, cosmetics, and functional foods. Furthermore, as rules evolve, CBD oil is projected to play an increasingly important role in sports medicine, veterinary care, and customized medicine.

CBD Oil Market Statistics

  • The global CBD oil market, generating USD 5.24 billion in 2024, projects a robust CAGR exceeding 15.1% from 2025 to 2033
  • North America heads the market with a substantial USD 3.09 billion of revenue in 2024
  • Asia-Pacific is projected to grow with exponential CAGR of 15.8%
  • Based on source, hemp derived CBD oil sub-segment accomplished 60% of share in 2024
  • A discernible trend in the CBD oil market is consumers are using CBD for anxiety, pain relief, and sleep disorders

Download Sample Report Copy: https://www.acumenresearchandconsulting.com/request-sample/3781

CBD Oil Market Dynamics

Legalization and Regulatory Approvals in Various Countries Fuels the CBD Oil Market Value

CBD oil's legalization and regulatory approval in various nations is considerably boosting cannabidiol (CBD) oil market expansion by allowing for wider use across industries. As governments acknowledge CBD's therapeutic promise, they are developing clear criteria to promote product development and consumer access. Countries such as the United States, Canada, Germany, and the United Kingdom have enacted advantageous legislation, instilling confidence in manufacturers and investors. With legal certainty, the pharmaceutical, health, and food businesses are rapidly adding CBD into their goods, broadening the market reach. As more nations ease restrictions, the global cannabidiol oil market is expected to witness sustained expansion.

Growth in E-Commerce and Direct-To-Consumer Sales Channels Offer Significant CBD Oil Market Opportunity

The expansion of e-commerce and direct-to-consumer (DTC) sales channels creates a tremendous opportunity for the cannabidiol oil market by allowing firms to access a larger audience. For example, according to the India Brand Equity Foundation (IBBF), India's e-commerce platforms reached a critical milestone, with a GMV of US$ 60 billion in fiscal year 2023, a 22% increase over the previous year. Online platforms appeal to health-conscious consumers by offering convenience, product diversity, and discreet purchasing options. CBD brands may engage with clients directly, giving instructional information and personalized recommendations, thanks to lower legal barriers than traditional retail. The direct-to-consumer strategy increases brand loyalty and trust by allowing businesses to control pricing, quality, and the customer experience. Furthermore, developments in digital marketing and social media have boosted CBD product awareness, fueling online sales growth.

CBD Oil Market Segmentation

The global market for CBD oil has been segmented into, source, product type, application, distribution channel, and region.

  • Source is classified into marijuana derived CBD oil, and hemp derived CBD oil
  • Product type are divided into full-spectrum CBD oil , broad-spectrum CBD oil, and CBD isolate
  • Application are categorized into pharmaceuticals, personal care and cosmetics, food and beverages, and wellness
  • Distribution channel are sub-segmented into online retail , pharmacies & drug stores, specialty stores , and supermarkets & hypermarkets
  • The CBD oil market is geographically split into North America, Europe, APAC, Latin America, and the Middle East and Africa

CBD Oil Market Regional Outlook

In terms of CBD oil market analysis, North America leads the way due to early legalization, widespread consumer awareness, and a well-established cannabis business, particularly in the United States and Canada. Regulatory advancements, such as the FDA's clearance of CBD-based pharmaceuticals, add to industry growth. For instance, according to the Federal Register, the FDA has approved one cannabis-derived drug product, EPIDIOLEX (cannabidiol), as well as three synthetic cannabis-related drug products, MARINOL (dronabinol), SYNDROS (dronabinol), and CESAMET (nabilone). Furthermore, the availability of CBD products in pharmacies, e-commerce platforms, and retail outlets strengthens North America's dominance in the cannabidiol (CBD) oil market.

Asia-Pacific cannabidiol oil market is quickly rising as legislative frameworks evolve, enabling for broader commercialization and increased public acceptance. Investments in clinical research, pharmaceutical advances, and food-grade CBD products are driving industry expansion. As more Asian nations develop clear rules, the region is emerging as a critical hub for CBD-based treatments, supplements, and cosmetics.

CBD Oil Market Players

CBD oil companies profiled in the report include Evora Worldwide, Aurora Cannabis Inc, Bluebird Botanicals, Hempstrol, BIOTA Biosciences LLC, Medical Mary, LLC, Neurogan, Charlotte’s Web, Elixinol, Endoca, Green Roads, Health Horizons, and Medterra CBD.

Buy Now This Report: https://www.acumenresearchandconsulting.com/buy-now/0/3781

CBD Oil Market Key Insights

Parameter

Details

Size in 2024

USD 5.24 Billion

Forecast by 2033

USD 18.34  Billion

CAGR During 2025 - 2033

15.1%

Largest Source Segment (% share 2024)

Hemp Derived CBD Oil– 60%

Largest Region Size (2024)

North America - USD 3.09 Billion

Fastest Growing Region (% CAGR)

Asia-Pacific– 15.8%

Key Players Covered

Evora Worldwide, Aurora Cannabis Inc, Bluebird Botanicals, Hempstrol, BIOTA Biosciences LLC, Medical Mary, LLC, Neurogan, Charlotte’s Web, Elixinol, Endoca, Green Roads, Health Horizons, and Medterra CBD.

Request Customization

Request Customization

Mr. Richard Johnson

Acumen Research and Consulting

India: +91 8983225533

E-mail: [email protected]

Acumen Research and Consulting

Contact Us

Would you like to get in touch? We'll be happy to talk!

Press Contact